Role of Genomic Variants in the Response to Biologics Targeting Common Autoimmune Disorders

doi 10.22215/etd/2016-11456
Full Text
Abstract

Available in full text

Date

Unknown

Authors
Publisher

Carleton University

Related search

Targeting Neuroplasticity, Cardiovascular, and Cognitive-Associated Genomic Variants in Familial Alzheimer’s Disease

Molecular Neurobiology
NeuroscienceNeurologyCellularMolecular Neuroscience
2018English

Determinants of Variable Response to Simvastatin Treatment: The Role of Common Variants of SCAP, SREBF-1a and SREBF-2 Genes

Pharmacogenomics Journal
Molecular MedicineGeneticsPharmacology
2005English

Targeting the Peripheral Inflammatory Response to Stroke: Role of the Spleen

Translational Stroke Research
NeuroscienceNeurologyCardiovascular MedicineCardiology
2014English

Clinical Consequences of Targeting IL-17 and TH17 in Autoimmune and Allergic Disorders

Current Allergy and Asthma Reports
ImmunologyPulmonaryAllergyRespiratory Medicine
2013English

Copy Number Variation at 22q11.2: From Rare Variants to Common Mechanisms of Developmental Neuropsychiatric Disorders

Molecular Psychiatry
PsychiatryMolecular NeuroscienceMental HealthMolecular BiologyCellular
2013English

Correction: Common Genomic Variants Associated With Variation in Plasma Lipoproteins in Young Aboriginal Canadians

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
1997English

Role of Common and Rare APP DNA Sequence Variants in Alzheimer Disease

Neurology
Neurology
2012English

Targeting the Fc Receptor in Autoimmune Disease

Expert Opinion on Therapeutic Targets
Molecular MedicineDrug DiscoveryClinical BiochemistryPharmacology
2014English

Autoimmune Thyroid Disorders

Journal of Thyroid Research
EndocrinologyMetabolismDiabetes
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy